Dr. Mukesh Kumar, MBA, PhD, RAC, DABRM
Creator & Scientific Authority
PROStemEX is a regenerative science and biotechnology platform dedicated to advancing the responsible development, preservation, and distribution of next-generation biological products derived from adipose tissue–based cellular systems.
At the scientific core of PROStemEX is Dr. Mukesh Kumar, a globally recognized leader in biotechnology, regulatory science, and clinical development. With more than 18 years of experience across the healthcare and life sciences industries, Dr. Kumar is a serial entrepreneur, founder of multiple biotechnology ventures and a leading expert in regulatory strategy, clinical trials, and innovative product development. His work has contributed to the advancement of over 100 medical products and hundreds of clinical trials worldwide, positioning him among the foremost authorities in translational and regenerative medicine.
Under his scientific leadership, PROStemEX operates with a strong commitment to quality, compliance, and innovation, ensuring that all processes align with the highest standards in biotechnology and global regulatory frameworks.
Over the past decade, PROStemEX has evolved alongside leading scientists, clinicians, and specialized laboratories, refining advanced protocols for the sourcing, handling, and application of adipose-derived biological materials.
Adipose tissue is widely recognized as one of the richest sources of mesenchymal stromal cells (MSCs) and cellular signaling components. These elements play a critical role in intercellular communication and tissue environment modulation, making adipose-derived systems a central focus in modern regenerative science.
PROStemEX supports physicians, research professionals, and wellness practitioners by providing high-quality biological materials, advanced preservation systems, and educational resources designed to explore emerging applications in a responsible and scientifically informed manner.
Our multidisciplinary team integrates expertise in biotechnology, clinical collaboration, medical communications, and regenerative research logistics, ensuring strict standards of quality, consistency, and traceability.
The company’s communications and strategic development are led by Jose Antonio Bedregal F., Chief Marketing Officer, working in coordination with a global network of scientists, clinicians, and research collaborators.
Together, we are committed to advancing the future of cellular preservation, adipose-derived biological systems, and responsible regenerative science.